Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 1 of 8
1  |  2  |  3  |  4  |  5  |  6  >   >>   >| 

Business Achievements
Tuesday, May 15, 2018   (0 Comments - view/add)
TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational »
TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platfo...
Monday, May 14, 2018   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Expanded Patent Coverage »
HedgePath Pharmaceuticals Announces Expanded Patent Coverage   HPPI's patent portfolio expands with clai...
Monday, May 14, 2018   (0 Comments - view/add)
AxoGen, Inc. Announces Closing of Public Offering of Common Stock »
AxoGen, Inc. Announces Closing of Public Offering of Common Stock   ALACHUA, Fla., May 14, 2018 (GLOBE NEWSWIRE...
Saturday, May 12, 2018   (0 Comments - view/add)
UCF launches Orlando's first life science incubator »
UCF launches Orlando's first life science incubator By Naseem S. Miller Contact Reporter Orlando Sentinel...
Wednesday, May 2, 2018   (0 Comments - view/add)
Morphogenesis, Inc Raises $16 Million to Advance into Human Clinical Trials »
FOR IMMEDIATE RELEASE   Morphogenesis, Inc Raises $16 Million to Advance into Human Clinical Trials...
Monday, April 30, 2018   (0 Comments - view/add)
FDA Authorizes CTD to Proceed with Extension Protocol to US Phase I Trappsol(R) Cyclo(TM) Trial for »
FDA Authorizes CTD to Proceed with Extension Protocol to US Phase I Trappsol(R) Cyclo(TM) Trial for Niemann-Pick Disease T...
Thursday, April 26, 2018   (0 Comments - view/add)
FAU and Max Planck Team Up on First Joint Position »
FAU and Max Planck Team Up on First Joint Position   Florida Atlantic University and Max Planck Florida...
Wednesday, April 25, 2018   (0 Comments - view/add)
Noven Announces Successful Resolution of FDA Warning Letter »
Noven Announces Successful Resolution of FDA Warning Letter April 25, 2018 09:08 AM Eastern Daylight Time...
Wednesday, April 25, 2018   (0 Comments - view/add)
BlinkBio, Inc. Announces Issuance of U.S. Patent No. 9,931,407 Covering the Company’s Broadly Enabli »
BlinkBio, Inc. Announces Issuance of U.S. Patent No. 9,931,407 Covering the Company’s Broadly Enabling SiLinker and Payloa...
Monday, April 23, 2018   (0 Comments - view/add)
CTD Holdings Closes $2.00 Million Private PlacementCTD Holdings Closes $2.00 Million Private Placeme »
CTD Holdings Closes $2.00 Million Private Placement ALACHUA, FL -- (Marketwired) -- 04/23/18 -- CTD Holdings, Inc. (OT...
Thursday, April 19, 2018   (0 Comments - view/add)
CTD Holdings Finalizes Cooperative Agreement for Alzheimer's Disease Research Program »
CTD Holdings Finalizes Cooperative Agreement for Alzheimer's Disease Research Program ALACHUA, FL -- (Marketwired) -...
Wednesday, April 11, 2018   (0 Comments - view/add)
TherapeuticsMD Enters Into Label Negotiations for TX-004HR »
TherapeuticsMD Enters Into Label Negotiations for TX-004HR April 11, 2018 06:00 AM Eastern Daylight Time...
Thursday, March 29, 2018   (0 Comments - view/add)
Concept Companies announces North Florida Regional Medical Center Primary Care facility to be first »
Concept Companies announces North Florida Regional Medical Center Primary Care facility to be first tenant in Markets West...
Wednesday, February 28, 2018   (0 Comments - view/add)
Exclusive: Jacksonville's fastest-growing company commits to stay, eyes public offering »
Exclusive: Jacksonville's fastest-growing company commits to stay, eyes public offering   By Will...
Thursday, February 22, 2018   (0 Comments - view/add)
FAU Brain Institute Awarded $780,000 From Stiles-Nicholson Foundation To Launch ASCEND Program »
FAU Brain Institute Awarded $780,000 From Stiles-Nicholson Foundation To Launch ASCEND Program Palm Beach County Resear...
Monday, February 5, 2018   (0 Comments - view/add)
Jupiter Orphan Therapeutics in Process to Submit IND for MPSI and Other Indications »
Jupiter Orphan Therapeutics in Process to Submit IND for MPSI and Other Indications   JUPITER, Fla. , Fe...
Thursday, January 25, 2018   (0 Comments - view/add)
New Siemens Partnership to Enhance BRIDG Efficiency »
New Siemens Partnership to Enhance BRIDG Efficiency Posted By zkotala On January 25, 2018 @ 3:14 pm In...
Tuesday, January 16, 2018   (0 Comments - view/add)
CTD Holdings' European Clinical Trial Adopted by National Institute for Health Research of England »
CTD Holdings' European Clinical Trial Adopted by National Institute for Health Research of England Collaboration Wil...
Thursday, January 11, 2018   (0 Comments - view/add)
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regula »
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs...
Monday, January 8, 2018   (0 Comments - view/add)
MTD Micro Molding Announced as Processor of the Year Finalist »
FOR IMMEDIATE RELEASE Lindsay Mann, MTD Micro Molding Director of Marketing 508-248-0111 x33 lmann@mtdmicromoldi...
Sunday, January 7, 2018   (0 Comments - view/add)
F1 Oncology Announces Development Milestone and $10M Equity Investment »
F1 Oncology Announces Development Milestone and $10M Equity Investment Precision medicine-directed trial of AXL and ROR...
Thursday, January 4, 2018   (0 Comments - view/add)
INC Research/inVentiv Health Becomes Syneos Health™ »
INC Research/inVentiv Health Becomes Syneos Health™ RALEIGH, N.C. – January 4, 2018 – INC Research/inVe...
Wednesday, January 3, 2018   (0 Comments - view/add)
Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA »
January 3, 2018   Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio o...
Thursday, December 28, 2017   (0 Comments - view/add)
TherapeuticsMD Announces Submission of New Drug Application for TX-001HR »
December 28, 2017   TherapeuticsMD Announces Submission of New Drug Application for TX-001HR  ...
Wednesday, December 13, 2017   (0 Comments - view/add)
NeuX Technologies and Muscle Activation Technique - Strategic Alliance - Integrated Solutions for Mu »
NeuX Technologies and Muscle Activation Technique - Strategic Alliance - Integrated Solutions for Musculoskeletal Conditio...
Tuesday, December 12, 2017   (0 Comments - view/add)
Espero BioPharma Provides Corporate Update and 2018 Objectives »
Espero BioPharma Provides Corporate Update and 2018 Objectives   December 12, 2017 08:30 ET | Sou...
Monday, December 11, 2017   (0 Comments - view/add)
FAU And Max Planck Society Unveil First-Of-Its-Kind Undergraduate Honors Program »
FAU And Max Planck Society Unveil First-Of-Its-Kind Undergraduate Honors Program BOCA RATON, Fla. , Dec. 11, 2017 /P...
Thursday, November 30, 2017   (0 Comments - view/add)
Catalyst Pharmaceuticals, Inc. Announces Closing of Previously Announced Public Offering »
Catalyst Pharmaceuticals, Inc. Announces Closing of Previously Announced Public Offering   November 30,...
Wednesday, November 29, 2017   (0 Comments - view/add)
TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR »
TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR   BOCA RATON, Fla.--( BUSINESS...
Tuesday, November 28, 2017   (0 Comments - view/add)
Asana Medical, Inc. Announces Corporate Name Change to Regentys »
Asana Medical, Inc. Announces Corporate Name Change to Regentys   MIAMI LAKES, FL – November 28, 2017 -- Asa...
Monday, November 20, 2017   (0 Comments - view/add)
NeuX Technologies and GoX Studio Execute Letter of Intent for a Strategic Alliance to Provide Meanin »
NeuX Technologies and GoX Studio Execute Letter of Intent for a Strategic Alliance to Provide Meaningful Solutions to Prev...
Thursday, November 16, 2017   (0 Comments - view/add)
AxoGen, Inc. Announces Pricing of Public Offering of Common Stock »
AxoGen, Inc. Announces Pricing of Public Offering of Common Stock   ALACHUA, Fla., Nov. 16, 2017 (GLOBE NE...
Wednesday, November 15, 2017   (0 Comments - view/add)
Intezyne's $10M Series A Preferred Round Wins SEBIO's 'Deal of the Year' »
Intezyne's $10M Series A Preferred Round Wins SEBIO's 'Deal of the Year'   TAMPA, Fla., Nov. 15, 2017...
Wednesday, November 8, 2017   (0 Comments - view/add)
Groundbreaking Florida Startup Raises Investor Interest at 20th Annual BioFlorida Conference »
Groundbreaking Florida Startup Raises Investor Interest at 20th Annual BioFlorida Conference Florida-based bi...
Wednesday, November 8, 2017   (0 Comments - view/add)
Research at Torrey Pines Institute Leads to Launch of Assuage Pharmaceuticals »
Research at Torrey Pines Institute Leads to Launch of Assuage Pharmaceuticals   Port St Lucie, FL (Novemb...

Displaying page 1 of 8
1  |  2  |  3  |  4  |  5  |  6  >   >>   >| 

About BioFlorida

BioFlorida represents nearly 6,000 establishments and research organizations in the biopharmaceutical, medical technology and bioagriculture sectors that collectively employ nearly 83,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

Email us for a regional Chapter sponsorship.

Connect